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The Putative Mevalonate Diphosphate Decarboxylase from Picrophilus
torridus Is in Reality a Mevalonate-3-Kinase with High Potential for
Bioproduction of Isobutene
Luca Rossoni,a Stephen J. Hall,a Graham Eastham,b Peter Licence,c Gill Stephensa
Department of Chemical and Environmental Engineering, Biorenewables and Bioprocessing Research Group, University of Nottingham, Nottingham, United Kingdoma;
Lucite International, Wilton Centre, Wilton, United Kingdomb; School of Chemistry, University of Nottingham, Nottingham, United Kingdomc
Mevalonate diphosphate decarboxylase (MVD) is an ATP-dependent enzyme that catalyzes the phosphorylation/decarboxyl-
ation of (R)-mevalonate-5-diphosphate to isopentenyl pyrophosphate in the mevalonate (MVA) pathway. MVD is a key enzyme
in engineered metabolic pathways for bioproduction of isobutene, since it catalyzes the conversion of 3-hydroxyisovalerate
(3-HIV) to isobutene, an important platform chemical. The putative homologue from Picrophilus torridus has been identified as
a highly efficient variant in a number of patents, but its detailed characterization has not been reported. In this study, we have
successfully purified and characterized the putative MVD from P. torridus. We discovered that it is not a decarboxylase per se
but an ATP-dependent enzyme, mevalonate-3-kinase (M3K), which catalyzes the phosphorylation of MVA to mevalonate-3-
phosphate. The enzyme’s potential in isobutene formation is due to the conversion of 3-HIV to an unstable 3-phosphate inter-
mediate that undergoes consequent spontaneous decarboxylation to form isobutene. Isobutene production rates were
as high as 507 pmol min1 g cells1 using Escherichia coli cells expressing the enzyme and 2,880 pmol min1 mg protein1 with
the purified histidine-tagged enzyme, significantly higher than reported previously. M3K is a key enzyme of the novel MVA path-
way discovered very recently in Thermoplasma acidophilum. We suggest that P. torridus metabolizes MVA by the same pathway.
The mevalonate (MVA) pathway (1) is the main route for theproduction of isopentenyl pyrophosphate (IPP) from acetyl
coenzyme A (acetyl-CoA) in a diverse cohort of organisms, in-
cluding higher eukaryotes, archaea, a few eubacteria, fungi, and
plants (2). IPP is a key building block for a large family of metab-
olites such as isoprenoids, dolichols, and sterols that are crucial for
a wide variety of cellular functions (3). Many of these molecules
have found applications in medicine and agriculture or are used as
nutraceuticals, flavors, and fragrances (4, 5). Inhibition of the
MVA pathway may also be a target for the design of antibacterial
drugs (6).
More recently, the emergence of industrial synthetic biology
has led to more and more examples of metabolic engineering us-
ing enzymes from the MVA pathway for sustainable production of
bioactive and industrial chemicals (7). Products include amor-
pha-4,11-diene (the precursor to artemisinin) (8, 9), limonene
and -carotene (10–12), a range of sesquiterpenes with potential
applications in cosmetics, pharmaceuticals, and jet fuels (13–15),
and other biofuels, such as prenol, isoprenol, or other C5 com-
pounds (16, 17).
A noteworthy example is the use of mevalonate diphosphate
decarboxylase (EC 4.1.1.33) (MVD) to produce isobutene. In the
classical MVA pathway, MVD catalyzes the final step, where it
produces IPP from (R)-mevalonate-5-diphosphate (MVAPP) in
an irreversible reaction dependent upon ATP (Fig. 1A). MVAPP is
phosphorylated first, and consequent decarboxylation occurs
with the concomitant release of inorganic phosphate. With the
same mechanism, classical MVDs also catalyze the conversion of
the nonphosphorylated 3-hydroxyisovalerate (3-HIV) to isobutene
(Fig. 1B) (18). Isobutene is a small, highly reactive molecule, used
extensively as a platform chemical to manufacture a wide variety of
products (19, 20) including fuel additives, rubbers, and speciality
chemicals. The global demand for isobutene produced from petro-
chemical sources was estimated to be around 10 million metric tons
per year with a market value higher than 15 billion euros (21, 22).
Sustainable conversion of renewable feedstocks to isobutene using
engineered pathways containing MVD is, therefore, an important
target, although current microbial processes are still unsatisfactory
(20) compared with current petrochemical production. Neverthe-
less, Global Bioenergies (Evry, France) has recently announced a sec-
ond pilot plant study (23).
The first demonstration of isobutene production via MVD em-
ployed Escherichia coli engineered with the Saccharomyces cerevi-
siae mevalonate diphosphate decarboxylase homologue (ScMVD)
to catalyze the conversion of 3-HIV (18). A patent regarding the
production of 3-HIV from acetone and acetyl-CoA was filed sub-
sequently (24), followed by further patents on the utilization of
MVDs from different sources to produce isobutene more effi-
ciently (25, 26). The concept was also extended to production of
other molecules such as isoprenol (27, 28).
Received 12 December 2014 Accepted 26 January 2015
Accepted manuscript posted online 30 January 2015
Citation Rossoni L, Hall SJ, Eastham G, Licence P, Stephens G. 2015. The putative
mevalonate diphosphate decarboxylase from Picrophilus torridus is in reality a
mevalonate-3-kinase with high potential for bioproduction of isobutene.
Appl Environ Microbiol 81:2625–2634. doi:10.1128/AEM.04033-14.
Editor: A. M. Spormann
Address correspondence to Luca Rossoni, enxlr@nottingham.ac.uk.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/AEM.04033-14.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
doi:10.1128/AEM.04033-14
The authors have paid a fee to allow immediate free access to this article.
April 2015 Volume 81 Number 7 aem.asm.org 2625Applied and Environmental Microbiology
 o
n
 M
arch 12, 2015 by Univ of Nottingham
http://aem
.asm
.org/
D
ow
nloaded from
 
Among the enzymes tested in the patents, one of the most
efficient decarboxylases for isobutene production (25, 27) is the
enzyme from Picrophilus torridus (GenBank [29] accession no.
AAT43941; locus tag PTO1356), which has been annotated as an
MVD (29, 30). The utilization of the putative P. torridus MVD
(putPtMVD) alone resulted in greater production titers, but even
higher yields were obtained when putPtMVD was mixed with
MVDs from other organisms (26, 28). To explain this, it has been
proposed that putPtMVD catalyzes phosphorylation of the sub-
strate faster than the subsequent decarboxylation. It has further
been proposed that the phosphorylated intermediate is released
and the additional mixture of other MVDs catalyzes decarboxyl-
ation of this intermediate to isobutene, providing an overall in-
crease in efficiency (26, 28). However, this hypothesis remains to
be tested, since putPtMVD has not yet been purified and charac-
terized, and the reaction mechanism has not been confirmed.
In the interest of unveiling more information on this poorly
characterized enzyme and its potential for isobutene formation,
we investigated putPtMVD in more detail. After sequence analysis,
putPtMVD was tested on the putative natural substrate MVAPP
and on other potential substrates. We found that the enzyme is not
an MVD. Instead, it belongs to a new class of enzyme, mevalonate-
3-kinase (M3K), very recently discovered in Thermoplasma acido-
philum (31, 32). Finally, putPtMVD’s ability to produce isobutene
from 3-HIV and its potential to produce other valuable small alk-
enes were investigated. Isobutene production rates were signifi-
cantly higher than reported previously (18).
This study provides important insights into a new enzyme in-
volved in the production of isoprenoids. Since M3Ks belong to a
new class of enzymes, there is considerable scope to discover new
biocatalysts with potential industrial uses. In particular, M3K cat-
alyzes isobutene formation at a higher rate than other biocatalysts.
MATERIALS AND METHODS
Materials. Bacterial strains and plasmids were purchased from Novagen.
Enzymes for gene cloning and strain transformation were purchased from
Fermentas, while purification kits for genes and plasmids were purchased
from Qiagen. Materials for protein purification and SDS-PAGE were pur-
chased from GE Healthcare and Bio-Rad. 3-Hydroxyisovalerate (3-HIV)
was purchased from TCI Chemicals, and 3-hydroxypropionate was pur-
chased from Manchester Organics. All other chemicals were purchased
from Sigma-Aldrich unless stated otherwise.
Sequence and structure analysis. Sequences were searched with
BLASTp (33) using the putPtMVD amino acid sequence (GenBank [29]
accession no. AAT43941) within nonredundant sequences database (No-
vember 2014). The E value cutoff was set at 0.1, and the 47 most significant
hits were aligned with MUSCLE (34). Phylogenetic reconstruction was
performed with MEGA6 (35) by the maximum likelihood test.
For multiple-sequence alignment of classical MVDs and Thermoplas-
matales putative MVDs, amino acid sequences used were from the follow-
ing organisms (with the respective GenBank [29] accession no. shown in
parentheses): Staphylococcus epidermidis (AAO03959), Saccharomyces
cerevisiae (AAC49252), Legionella pneumophila (AAU28109), Trypano-
soma brucei (EAN78728), Candida albicans (AAF19399), Homo sapiens
(AAC50440), Mus musculus (CAC35731), Rattus norvegicus (AAB00192),
Arabidopsis thaliana (AEE79204), Ginkgo biloba (AAV32433), Staphylo-
coccus aureus (BAB56753), Streptococcus pyogenes (AAK33797), Strepto-
coccus pneumoniae (CCP34068), Thermoplasma volcanium (BAB59465),
Thermoplasma acidophilum (CAC12426), Ferroplasma acidarmanus
(AGO61795), and Picrophilus torridus (AAT43941). Alignment was gen-
erated using MUSCLE (34) and rendered with ESPript (36).
Cloning. Genes encoding putPtMVD and ScMVD, optimized for ex-
pression in E. coli (see Fig. S2 and Fig. S3 in the supplemental material),
were synthesized by Biomatik with the inclusion of NdeI and NotI restric-
tion sites to facilitate insertion into a modified version of plasmid pET-
20b(), adapted for N-terminal histidine tagging. Escherichia coli
BL21(DE3)pLysS was transformed by heat shock, and the transformants
were selected on LB agar plates supplemented with carbenicillin (50 g/
ml), chloramphenicol (34 g/ml), and glucose (10 g/liter). E. coli was also
transformed with the empty plasmid and used as a control. Glycerol
stocks (8%) of transformants were stored at 80°C, and experimental
cultures were derived from single colonies grown overnight on LB agar at
37°C. For expression or whole-cell biotransformation assays, single colo-
nies from those plates were used to inoculate precultures.
Expression and purification. Overnight precultures (50 ml) of E. coli
strains were grown in LB medium (500 ml) with antibiotics and incubated
at 37°C with shaking at 160 rpm. At an optical density at 600 nm (OD660)
of approximately 0.6, protein expression was induced by adding isopro-
pyl--D-1-thiogalactopyranoside (IPTG) (0.4 mM). After 14 h, cells were
removed by centrifugation and resuspended in buffer A (20 mM sodium
phosphate, 30 mM imidazole, 500 mM NaCl [pH 7.4]) for subsequent
purification or in buffer B (50 mM Tris-HCl, 10 mM MgCl2, 20 mM KCl
[pH 7.5]) when the supernatants were to be used directly as crude extracts.
The cells were lysed with a Constant Systems cell disruption system, cell
debris was removed by centrifugation at 15,000  g for 15 min, and
protein expression was checked by SDS-PAGE (see below).
putPtMVD and ScMVD were purified at 4°C using an Akta protein
purification system. Crude extracts (10 ml) were applied to a HisTrap FF
crude column (1 ml), and proteins were eluted with a linear gradient of
buffer A containing 500 mM imidazole (1 ml/min). Elution was moni-
tored by UV (280 nm). Fractions (2 ml) were analyzed by SDS-PAGE (see
below), and those containing the protein of interest were combined. Buf-
fer A was exchanged with buffer B by several concentration/dilution cycles
using a Vivaspin sample concentrator. Fresh enzymes were used each
time.
SDS-PAGE was done with a Mini-Protean electrophoresis system us-
ing TGX precast gels stained with QC colloidal Coomassie protein stain.
Purity was estimated by visual observation. Total protein concentration in
crude extracts was determined with the Bio-Rad DC protein assay kit. The
concentrations of pure putPtMVD and ScMVD were calculated from A280
measurements with a NanoDrop ND1000 spectrophotometer (Thermo
Scientific) using a computed extinction coefficient of 22,015 and 53,650
M1 · cm1, respectively.
Enzyme assays. The activity of purified putPtMVD and ScMVD was
determined by coupling the release of ADP with NADH oxidation by
pyruvate kinase/lactate dehydrogenase (PK/LDH) (37-41), measured at
340 nm at 10-s intervals using an Agilent 8453 UV-visible spectrophotom-
eter. Assays were performed in 1-ml polymethyl methacrylate cuvettes
(BRAND) at 30°C in buffer B with the addition of 0.2 mM NADH, 0.5 mM
phosphoenolpyruvate (PEP), 5 mM ATP, aqueous glycerol solution of
PK/LDH (20 l) (catalog no. P0294; Sigma-Aldrich), and 10 to 50 g of
FIG 1 MVD reaction scheme. (A) The natural substrate of MVD is (R)-me-
valonate-5-diphosphate (MVAPP), which is converted to isopentenyl pyro-
phosphate (IPP). (B) MVD is also active on 3-hydroxyisovalerate (3-HIV) to
produce isobutene in S. cerevisiae (18).
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pure enzyme. Assays were equilibrated for 2 min and initiated by the
addition of substrate (see below). NADH concentrations were calculated
using an extinction coefficient of 6,220 M1 · cm1. One unit of enzyme
activity corresponds to production of 1 mol NADH per 1 min.
Substrate range and kinetic characterization. putPtMVD and ScMVD
were tested for activity with (R,S)-mevalonate-5-diphosphate (MVAPP),
(R,S)-mevalonate-5-phosphate (MVA-5P), and (R)-mevalonate (MVA),
all at 500 M. putPtMVD was also tested for activity with 3-hydroxy-
isovalerate (3-HIV), 3-hydroxybutyrate (3-HB), and 3-hydroxypropi-
onate (3-HP), at the same concentration.
For putPtMVD kinetic characterization, the MVA concentration range
was 75 to 900 M, and the 3-HIV and 3-HB concentrations range from 1
to 25 mM. For ScMVD kinetic characterization, the MVAPP concentra-
tion range was 50 to 300 M. When performing kinetic analyses for the
cosubstrate ATP, MVA and MVAPP were kept in excess (2 mM) and ATP
was kept in a range between 18.75 and 300 M. Maximum velocities
(Vmax) and Michaelis constants (Km) were estimated using the Michaelis-
Menten model of GraphPad Prism version 6.04.
Product identification. For isoprenol analysis by gas chromatogra-
phy-mass spectrometry (GC-MS) and phosphorylated MVA identifica-
tion by electrospray ionization-mass spectrometry (ESI-MS), products
were generated in reaction mixtures (1 ml) containing 5 mM MVA, 6 mM
ATP, and 50 g pure putPtMVD in buffer B at 30°C with shaking at 200
rpm. Incubation times are stated in the text. Control samples were pre-
pared in the same way but without adding the enzyme.
Enzymatic reaction mixtures for nuclear magnetic resonance (NMR)
were incubated for 24 h at 30°C with shaking at 200 rpm in reaction
mixtures described previously (31) but using a larger volume (300 l) and
a higher concentration of MVA and PEP (40 mM). Analytical standards of
MVA and MVA-5P were prepared at a concentration of 40 mM.
Formation of isobutene and other gaseous alkenes. Isobutene forma-
tion was investigated for both putPtMVD and ScMVD using whole cells, crude
extracts, and pure enzymes. Isobutene formation was linear until 48 h, so
production rates were calculated during this period. putPtMVD was also
tested for ethene and propene formation from 3-HP and 3-HB, respectively,
in crude extracts and with purified enzyme. Quantification of all gases was
performed by GC-MS.
(i) Whole-cell assays. E. coli strains were grown and induced as de-
scribed above. After 5 h, cells were collected by centrifugation at 15,000 
g for 15 min and resuspended in fresh medium containing IPTG. Reaction
mixtures (10 ml) containing harvested cells (20 g/liter) and 3-HIV (50
mM) were incubated at 37°C with shaking at 200 rpm in 30-ml glass vials
closed with gas-tight caps with polytetrafluorothylene (PTFE)-silicone
septa.
(ii) Crude extract and pure enzyme assays. Reaction mixtures (1 ml)
containing crude extracts (1 mg/ml total protein) or pure putPtMVD and
ScMVD (50 g), ATP (40 mM), and either 3-HIV, 3-HB, or 3-HP (40
mM) in buffer B were incubated at 30°C with shaking at 200 rpm in sealed
GC vials (nominal volume of 2 ml) with PTFE screw caps. For controls,
samples without the addition of enzymes were also analyzed. The reaction
mixtures were incubated at the temperatures stated in the text.
Analytical methods. (i) GC-MS. Samples were analyzed using an Agi-
lent 7890A GC-MS system equipped with a Restek Rxi-5ms capillary col-
umn (0.25 mm by 30 m by 0.25 m) and a 5975C inert mass selective
detector (MSD) with a quadrupole mass analyzer. Helium was used as a
carrier gas at 1.2 ml/min. Data analysis was done using the Agilent MSD
ChemStation software and by comparison with the mass spectra and re-
tention times of authentic standards.
For detection and quantification of isoprenol, samples of reaction
mixtures (250 l) were extracted with 750 l ethyl acetate, and the solvent
phase (1 l) was injected at an inlet temperature of 250°C and at a split
ratio of 100:1. The oven temperature was kept at 45°C for 5 min, increased
to 300°C at 20°C/min, and then held for 5 min. The retention time of
authentic isoprenol was 3.32 min, and a linear calibration curve was ob-
tained over a concentration range from 0.1 to 10 mM.
For detection and quantification of isobutene, propene, and ethene,
the headspace (100 l) was manually injected at an inlet temperature of
150°C and at a split ratio of 100:1. The oven temperature was kept at 40°C
for 5 min, increased to 200°C at 20°C/min, and then held for 5 min. The
retention times of authentic isobutene, propene, and isobutene were 1.42,
1.38, and 1.34 min, respectively. A linear calibration curve was obtained
for all gases over a concentration range from 4,000 to 200,000 pmol/ml. At
low product concentrations, sensitivity was increased by monitoring the
most characteristic ions in selected ion monitoring (SIM) mode. For
isobutene, the ions were 39, 41, and 56 m/z; for propene, they were 39, 41,
and 42 m/z; for ethene, they were 26 and 27 m/z.
(ii) ESI-MS. Reaction mixtures were filtered using a Vivaspin sample
concentrator to remove enzyme and quench the reaction. Filtrates were
analyzed by ESI-MS operating in the negative ion mode using a Varian
310-MS triple quadrupole (TQ) system controlled by a Varian Worksta-
tion version 6.9. Samples were diluted in 50% water–50% acetonitrile for
direct infusion at 0.05 ml/min. Multiple spectra (10 spectra) were aver-
FIG 2 Phylogenetic analysis. P. torridus putative MVD is indicated by a red
circle. The color of the line before the organism name in the dendrogram
shows the kingdom of the organism as follows: red line, the Bacteria kingdom;
blue line, the Fungi kingdom; green line, the Chromalveolata kingdom; black
line, the Archaea kingdom. The black bracket indicates archaea belonging to
the Thermoplasmatales order.
M3K from P. torridus
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aged to generate the data used in the figures. The masses of the negatively
charged ions discussed are mevalonate-3-phosphate (227 m/z) and me-
valonate (147 m/z), and the phosphate species are H2PO4 (97 m/z) and
PO3 (79 m/z). For tandem MS (MS-MS) acquisition, the isolation width
was set at 1 m/z, and the collision energy was set at 10 eV.
(iii) NMR. The samples were diluted to 600 l with 99.9% D2O.
Spectra were acquired at ambient temperature using a 500-MHz
Bruker AV(III)500 spectrometer equipped with a cryoprobe. Data
were processed and analyzed using ACD/NMR Processor version
12.01.
FIG 3 Multiple-sequence alignment. Conventional MVDs are indicated in black, and “MVD-like” proteins from the Thermoplasmatales order are shown in red.
Only highly conserved regions (outlined in blue) are depicted. Conservation of residues is denoted by colors: white amino acids on a red background are strictly
conserved; red amino acids on a white background are high in similarity. The numbering annotation is based on S. epidermidis MVD. Stars denote residues
involved in MVAPP interaction (cyan for C-1 carboxylate group and blue for diphosphate moiety and hydroxyl group). Triangles denote residues involved in
ATP interaction (red for phosphate groups, orange for purine ring and ribose).
TABLE 1 Kinetic constants of ScMVD, putPtMVD, PMD from H. volcanii and R. castenholzii, and M3K from T. acidophiluma
Enzyme Reference(s) Activity (U · mg1) Km (M)
b Km(ATP) (M) kcat (s
1) kcat/Km (s
1 · M1)b
P. torridus putMVD 3  0.1 131  18 (MVA) 23  0.1 1.9 1.5  102 (MVA)
S. cerevisiae MVD This study 7  0.7 133  28 (MVAPP) 61  6 5.4 4  102 (MVAPP)
S. cerevisiae MVD 39, 40 6.4  0.2 123  22 (MVAPP) 61  6 4.9 4  102 (MVAPP)
H. volcanii PMD 44 5.6  0.1 159  15 (MVA-5P) 289  15 3.5 2.2  102 (MVA-5P)
R. castenholzii PMD 45 NA 152  38 (MVA-5P) NA 1.7 1.1  102 (MVA-5P)
T. acidophilum M3K 31 NA 97  6 (MVA) NA 5.0 5.1  102 (MVA)
a Activity values refer to the rate of ADP formation coupled to NADH oxidation. Values for putPtMVD and ScMVD are calculated from enzyme assays at 30°C in 50 mM Tris-HCl
buffer, pH 7.5, with the addition of 10 mM MgCl2, 20 mM KCl, and 10 g of pure
putPtMVD or ScMVD. Assays were done in triplicate, and the means  standard errors of the
means for the kinetic constants are shown. Previous data for ScMVD, H. volcanii PMD, R. castenholzii PMD, and T. acidophilum M3K are taken from the literature. NA, not
available.
b Values are given for the respective substrate (in parentheses) of each enzyme (MVAPP, MVA-5P, or MVA).
Rossoni et al.
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RESULTS
Sequence analysis. Initially, a bioinformatics approach was used
to gain insights into the possible functionality of putPtMVD. A
BLASTp search for putPtMVD homologues and a phylogenetic
analysis revealed that proteins with the highest sequence identity
and similarity with putPtMVD are found mostly in members of the
Archaea domain, with higher values with enzymes from Ferro-
plasma acidarmanus, Thermoplasma volcanium, and T. acidophi-
lum, all members of the Thermoplasmatales order (Fig. 2; see Table
S1 in the supplemental material). Interestingly, putPtMVD has se-
quence identity and similarity of only 21% and 41%, respectively,
with Staphylococcus epidermidis MVD (SeMVD) (38), and only
18% and 36% with ScMVD (42), two enzymes that have been
verified to act catalytically as MVDs. This significant difference
opens the possibility that putPtMVD, and the other Thermoplas-
matales homologues, may be unrelated to classical MVDs.
To further investigate this hypothesis, a multiple-sequence
alignment was made between Thermoplasmatales homologues
and classical MVDs to compare important conserved regions and
residues known to be involved in substrate binding and enzyme
activity (Fig. 3). The classical MVDs were chosen on the basis of
their experimentally verified ability to catalyze decarboxylation of
MVAPP and the availability of structural, functional, and muta-
tion data. The regions for ATP binding and interaction with the
FIG 4 ESI-MS analysis. All spectra were collected in negative ion mode. The mass spectra are shown. (A) Control sample containing MVA but without added
enzyme; (B) sample containing MVA and putPtMVD; (C) MS-MS spectrum of 227 m/z ion yielding phosphate ions (97 and 79 m/z). The reaction was performed
in 50 mM Tris-HCl buffer, pH 7.5, with the addition of 10 mM MgCl2 and 20 mM KCl. Samples were analyzed after 24 h.
M3K from P. torridus
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C-1 carboxylate of MVAPP are very similar among the whole co-
hort (Fig. 3, positions 12, 101 to 111, and 144). However, strong
differences are seen in those regions particularly suggested to be
involved in the binding of the diphosphate moiety of MVAPP or
directly involved in the catalytic mechanism (Fig. 3, positions 17
to 21, 72, 139 to 141, 192 to 196, and 283). This information
suggests that putPtMVD may differ significantly from classical
MVDs (18 to 21% sequence identity). In fact, it shares greater
sequence identity (38%) with the newly discovered T. acidophilum
mevalonate-3-kinase (TaM3K) (31, 32) (Fig. 3), which was also
previously annotated as an MVD. Unlike MVDs, the substrate for
TaM3K is (R)-mevalonate (MVA), and the enzyme acts as a kinase
to produce (R)-mevalonate-3-phosphate (MVA-3P) and not as a
decarboxylase (31, 32). The crystal structure of TaM3K was very
recently described, and the importance of some of the amino acid
differences mentioned above in comparison to classical MVDs
was confirmed (43).
Nevertheless, the sequence identity between TaM3K and
putPtMVD is still relatively low, leaving questions about their
functional similarity. Since putPtMVD is an important indus-
trial enzyme, we decided to investigate the substrate specificity
and reaction selectivity to identify its real biological function.
Search for putPtMVD’s natural substrate. The sequence of the
gene encoding putPtMVD was optimized for expression in E. coli
(see Fig. S2 in the supplemental material), transformed, and ex-
pressed in E. coli BL21(DE3)/pLysS with an N-terminal histidine
tag (6His). Overnight expression under IPTG induction lead to
synthesis of a protein of around 40 kDa that, after purification on
a Ni Sepharose column, was at least 95% pure.
Activity was investigated using a coupled enzymatic assay al-
ready in use for the analysis of substrate phosphorylation by clas-
sical MVDs (37–41). There was no activity when MVAPP was
tested as the substrate. (R,S)-Mevalonate-5-phosphate (MVA-5P)
was also tested, since this is the substrate for another enzyme,
MVA-5P decarboxylases (phosphomevalonate decarboxylase
[PMD]), similar to MVD, and recently discovered in Archaea and
Bacteria (44, 45). However, there was no detectable activity on
MVA-5P. Finally, MVA was tested as well, since it is the substrate
for TaM3K (31, 32). With MVA, activity was detected at a rate of
3.01 U mg1 (Table 1). Overall, the substrate range is consistent
with the hypothesis that putPtMVD is actually an M3K, similar to
TaM3K, rather than a classical MVD, since it did not act on
MVAPP. As a comparison, the classical ScMVD (sequence avail-
able in Fig. S3 in the supplemental material) was expressed and
purified in the same way as putPtMVD and tested on the same
substrates. As expected, ScMVD activity was observed only with
MVAPP and not with MVA-5P or MVA (Table 1).
In order to understand whether MVA is putPtMVD’s natural sub-
strate, we measured and compared the kinetic parameters for MVA
phosphorylation by putPtMVD with MVAPP phosphorylation by Sc-
MVD (Table 1). The kinetic parameters for ScMVD were very similar
to those reported previously (Table 1) (39, 40). The magnitude of the
kinetic constants and activities of putPtMVD with MVA were similar
to those of ScMVD with MVAPP, consistent with the hypothesis that
MVA is the natural substrate of putPtMVD, as MVAPP is for ScMVD.
In addition, the kinetic parameters reported in the literature for the
newly discovered PMDs from Haloferax volcanii (44) and Rosei-
flexus castenholzii (45), and of M3K from T. acidophilum are also
similar in magnitude (Table 1).
New enzyme classification of putPtMVD. To discriminate be-
tween putPtMVD being an MVD or an M3K, further experiments
were needed, since the coupled enzyme assay monitors only ADP
release and not the actual decarboxylation of the intermediate.
The expected reaction product would be 3-methylbut-3-en-1-ol
(isoprenol) if MVA is phosphorylated and then decarboxylated.
Therefore, attempts were made to detect isoprenol by gas chro-
matography-mass spectrometry (GC-MS). Pure putPtMVD was
mixed with a high concentration of MVA (5 mM), and the pres-
ence of isoprenol was checked at intervals (24, 48, and 96 h). Even
after a long incubation time (96 h), isoprenol was not observed,
FIG 5 NMR analysis. The full spectrum is available in the supplemental ma-
terial (see Fig. S6 in the supplemental material). The MVA-3P structure is
shown at the top, and the peaks corresponding to carbons 1 to 6 are shown at
the bottom. Values are in parts per million (ppm). The reaction was performed
as previously described (31) using MVA as the substrate at a concentration of
40 mM. Samples were analyzed after 24 h.
FIG 6 M3K reaction scheme. (A) The natural substrate of M3K is (R)-meval-
onate (MVA), which is converted to (R)-mevalonate-3-phosphate (MVA-3P).
(B) PtM3K is also active on 3-hydroxyisovalerate (3-HIV) and 3-hydroxybu-
tyrate (3-HB) to produce 3-phosphoisovalerate (3-PIV) and 3-phosphobu-
tyrate (3-PB), respectively.
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suggesting that putPtMVD does not catalyze MVA decarboxyl-
ation per se.
Therefore, we tested putPtMVD for formation of a phosphory-
lated product from MVA, analyzing the reaction product by elec-
trospray ionization-mass spectrometry (ESI-MS). An ion with
m/z 227 was detected only in the samples where putPtMVD was
added to the reaction mixture, which corresponded to the mass of
the expected phosphorylated MVA (Fig. 4B). In the control with-
out added enzyme, this ion was not present. Instead, an ion with
147 m/z was among those with the highest intensity, correspond-
ing to unreacted MVA (Fig. 4A). A higher background noise was
observed in the MS trace for the control compared to the test. This
was probably due to a lower response of MVA in the ESI-MS
analysis compared to the phosphorylated MVA. Unreacted MVA
was also observed in samples where the enzyme was added, mean-
ing that full conversion was not reached (Fig. 4B). As a confirma-
tion that the 227 m/z ion corresponded to phosphorylated MVA,
MS-MS analysis of the isolated product generated peaks corre-
sponding to phosphate ions (H2PO4
 [97 m/z] and PO3
 [79 m/z]
[Fig. 4C]).
Although the phosphorylated MVA product is likely to be
MVA-3P, it must be mentioned that the observed 227 m/z ion
could also correspond to MVA-5P, the alternative phosphoryla-
tion product. Therefore, we used 13C NMR analysis to distinguish
between the two isomers by analyzing the coupling between 13C
and 31P. Any coupling will result in fine structure (doublets) asso-
ciated with the signals for each carbon atom within three bonds of
31P. The 13C NMR spectrum of authentic MVA showed six singlet
peaks, whereas the spectrum of authentic MVA-5P showed split-
ting at carbons 4 and 5 as expected (see Fig. S4 and Fig. S5 in the
supplemental material). In contrast, 13C NMR spectrum of the
product mixture after phosphorylation of MVA by pure putPtMVD
showed splitting at carbons 2 to 4 and 6, consistent with phosphory-
lation at position 3 (Fig. 5; see Fig. S6 in the supplemental material).
Thus, analysis of the sequence, substrate range, and reaction
products demonstrated that putPtMVD has been annotated incor-
rectly and that it is actually a mevalonate-3-kinase that acts on
MVA to produce MVA-3P (Fig. 6A). Therefore, we propose that
“putPtMVD” should be renamed PtM3K. From now on, it is re-
ferred to as PtM3K throughout the text.
Formation of isobutene. PtM3K was identified as a preferred
enzyme for the production of isobutene from 3-HIV (25). There-
fore, activity of PtM3K on 3-HIV was first investigated. Compared
to the natural substrate MVA, the catalytic efficiency was very low,
with a 20-fold-higher Km and a 1,000-fold-lower kcat/Km (Table 2).
The Km and kcat/Km were lower (2.35 mM) and higher (4.25 
105 s1 M1), respectively, than those disclosed previously
(9.17 mM and 2  105 s1 M1 [26]).
Next, isobutene formation was compared using whole cells
expressing PtM3K, crude extract containing PtM3K, and pure
PtM3K (Table 3). Production rates were compared with ScMVD
under the same conditions, since ScMVD also catalyzes isobutene
formation from 3-HIV (18). The experiments were performed in
sealed vials so that isobutene could be measured by GC-MS anal-
ysis of the headspace. Since isobutene can form spontaneously
from 3-HIV (46), controls with no enzyme were always compared,
and the rate of isobutene formation in controls was subtracted
from the enzymatic reactions. As expected (18, 25, 27), both
PtM3K and ScMVD catalyzed formation of isobutene (Table 3). In
controls without ATP, isobutene formation was similar to those
observed for controls without enzyme (data not shown). This
confirms that the reactions catalyzed by PtM3K and ScMVD are
ATP dependent. PtM3K catalyzed isobutene formation at rates
consistently higher than ScMVD under all assay conditions. With
the pure enzyme, an 11-fold improvement was observed (Table
3). Very interestingly, a further 110-fold enhancement (from 26 to
2,880 pmol min1 mg protein1) was observed for purified
PtM3K when the temperature of the assay was increased from 30
to 50°C (Table 3). However, it must be noted that PtM3K is not a
true decarboxylase but a kinase, and therefore, isobutene production
depends on formation of an unstable intermediate, 3-phospho-
isovalerate (3-PIV) (Fig. 6B) that decarboxylates nonenzymatically.
For this reason, it is possible that the higher production rate observed
at higher temperature is due to an increased rate of spontaneous de-
carboxylation of 3-PIV. We wish to note that the rates of isobutene
formation obtained using PtM3K were even higher than reported
previously using enhanced variants of ScMVD obtained with protein
engineering tools (18).
Formation of other gaseous alkenes. In order to test the use of
PtM3K for production of other small, industrially useful alkenes,
TABLE 2 Kinetic constants of PtM3K on four different substratesa
Substrate Activity (U · mg1) Km (M) kcat (s
1) kcat/Km (s
1 · M1)
Mevalonate (MVA) 3  0.1 131  18 1.9 1.5  102
3-Hydroxyisovalerate (3-HIV) 0.17  0.01 2,348  574 0.1 4.25  105
3-Hydroxybutyrate (3-HB) 0.14  0.01 3,163  637 0.1 2.9  105
3-Hydroxypropionate (3-HP) ND ND ND ND
a Activity values refer to the rate of ADP formation coupled to NADH oxidation. Values are calculated at 30°C in 50 mM Tris-HCl buffer, pH 7.5, with the addition of 10 mM
MgCl2, 20 mM KCl, and 50 g of pure PtM3K (for MVA, the amount of pure PtM3K added was 10 g). Assays were done in triplicate, and the means  standard errors of the
means for the kinetic constants are shown. ND, not detected.
TABLE 3 Isobutene formation rates for PtM3K and ScMVDa
Enzyme
Isobutene formation rate
Whole cells
(pmol ·
min1 · g
cells1)
Crude extract
(pmol ·
min1 · mg
total
protein1)
Purified protein (pmol ·
min1 · mg protein1)
30°C 50°C
PtM3K 507  137 261  19 26  2 2,880  140
ScMVD 7.4  1.5 1.6  0.3 2.3  1.2 NA
a The concentration of 3-HIV used was 50 mM. For the crude extract and purified
enzyme experiments, 40 mM ATP was added. Assays were done in triplicate, and the
means  standard errors of the means for formation rates are shown. Isobutene was
quantified by GC-MS analysis of the headspace. Due to the very low aqueous solubility
of isobutene (51), its concentration in the liquid phase was considered negligible, and it
was not taken into consideration. NA, not available.
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we investigated its activity on two other substrates, 3-hydroxypro-
pionate (3-HP) and 3-hydroxybutyrate (3-HB). These substrates
have the potential to be converted to ethene and propene (19) if
they can be phosphorylated at position 3 and if the intermediates
are sufficiently unstable to decarboxylate spontaneously.
Although the enzyme was able to phosphorylate 3-HB (Fig. 6B)
with kinetics similar to those for 3-HIV (Table 2), no propene was
detected by GC-MS using either crude extract or purified enzyme,
even at a temperature of 50°C. This suggests that, as for MVA, the
phosphorylated intermediate is too stable to decarboxylate. As for
3-HP, the enzyme was not even able to catalyze its phosphoryla-
tion. This suggests that one or two methyl substituents are re-
quired at position C-3 to enable binding of the substrate to the
enzyme and/or for catalytic activity.
DISCUSSION
We demonstrated that the P. torridus enzyme (GenBank [29] ac-
cession no. AAT43941; locus tag PTO1356), so far classified as
mevalonate diphosphate decarboxylase, is actually a mevalonate-
3-kinase, since it acted on MVA to produce MVA-3P (Fig. 6A).
This intermediate appeared to be stable, since no decarboxylation
of MVA was observed and MVA-3P could be detected in the re-
action mixture. Classical MVDs also act as kinases, but MVAPP is
the substrate instead. The phosphorylation results in formation of
a transient tertiary phosphorylated intermediate that quickly re-
leases inorganic phosphate with concomitant decarboxylation
(38, 47, 48) or even in a concerted manner (49). Thus, the differ-
ence in substrate specificity (MVA versus MVAPP) may account
for the differences in the ability of PtM3K and MVDs to act as
decarboxylases. Differences in amino acid composition in regions
suggested to be involved in the catalytic mechanism (Fig. 3, posi-
tions 281 to 284) may also affect the enzymatic mechanism, as
recently confirmed for TaM3K (43).
The results of our sequence analysis suggest that M3Ks may
also be found in other members of the Thermoplasmatales order in
addition to T. acidophilum (31, 32) and P. torridus. This raises
questions about the pathway for MVA metabolism in these organ-
isms, since there is little evidence for the operation of the classical
MVA pathway. In the classical MVA pathway, MVA is doubly
phosphorylated to MVAPP and consequently converted to IPP by
MVD (Fig. 7). In the absence of MVD, MVA must undergo a
different route to be converted to IPP. Indeed, the discovery of
TaM3K led to the description of a completely new type of MVA
pathway in T. acidophilum, where M3K catalyzes the initial step in
the metabolism of MVA (31, 32) (Fig. 7) and MVA-3P-5-kinase
(M3P5K) (GenBank [29] accession no. CAC11895) catalyzes the
conversion of MVA-3P to mevalonate-3,5-bisphosphate (MVA-
3,5PP). The enzymes catalyzing conversion of MVA-3,5PP to iso-
pentenyl phosphate (IP) have not yet been identified, and this
provides an excellent target for future research. IP is finally con-
verted to IPP via IP kinase (IPK) (50).
We have now shown that an M3K is also present in P. torridus.
Since a strongly similar counterpart of M3P5K is also found in
P. torridus (see Table S7 in the supplemental material), P. torridus
is also likely to contain this new type of MVA pathway (Fig. 7). It
should be noted that this pathway is distinct from the mevalonate-
5-kinase (M5K) pathway found in Haloferax volcanii (44) and
Roseiflexus castenholzii (45) (Fig. 7). Neither of the key enzymes,
(M5K and PMD) are present in T. acidophilum (50), and there is
no experimental or sequence homology evidence to support their
presence in P. torridus. Overall, this suggests that P. torridus pro-
duces IPP via the newly discovered M3K pathway.
FIG 7 Classical MVA pathway and modified routes. The classical MVA pathway and the modified routes (via M5K and PMD and the newly suggested route in
T. acidophilum) are specifically indicated. Enzyme abbreviations are as follows: M5K, mevalonate-5-kinase; PMK, phosphomevalonate (mevalonate-5-phos-
phate) kinase; MVD, mevalonate-5-diphosphate decarboxylase; PMD, phosphomevalonate (mevalonate-5-phosphate) decarboxylase; IPK, isopentenyl phos-
phate kinase; M3K, mevalonate-3-kinase.
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Regarding the use of PtM3K and MVDs for isobutene produc-
tion, we found that PtM3K exhibits much higher catalytic effi-
ciency than ScMVD. Unlike ScMVD, the potential of PtM3K in
forming the gas is not due to direct decarboxylation but to the
generation of the unstable intermediate, 3-PIV (Fig. 6B). The
isobutene production rates for PtM3K were not disclosed until
now and were found here to be significantly higher than reported
previously for ScMVD (18). Having an enzyme with a higher rate
of isobutene formation from 3-HIV is an important step for the
production of renewable isobutene, since this further reduces the
gap toward commercial application. With ScMVD, it was esti-
mated that the level of cellular activity obtained after enhance-
ment of the enzyme with protein engineering (98 pmol min1 g
cells1 with whole cells [18]) was about 106-fold below what is
needed for a commercial process (18, 20). With PtM3K, the rate is
increased 5-fold (507 pmol min1 g cells1). Although this is still
far from industrial application, the discovery of a new M3K class
of enzymes opens the possibility to screen other, related enzymes
for isobutene formation or to undertake protein engineering to
improve the production rates still further.
As for the potential of PtM3K to be used for the production of
other gaseous alkenes such as ethene and propene, unfortunately,
we were not able to observe any product formation. The enzyme
was able to phosphorylate 3-HB (Fig. 6B and Table 2), but under
the tested conditions, the 3-P intermediate did not spontaneously
decarboxylate to propene. This could be due to the 3-phosphobu-
tyrate (3-PB) intermediate being more stable than 3-PIV. The
absence of an electron-donating methyl group on 3-PB could re-
duce the electron density relative to the tertiary carbon of the
intermediate and slow down the rate of the decarboxylation,
thought to occur via a carbocation intermediate (42).
To conclude, from a microbiological/evolutionary point of
view, our study raises important questions on the presence of
alternative MVA pathways in Archaea. It is even possible that vari-
ant MVA pathways are present among members of all kingdoms
in nature (45). Many plant, bacterial, and fungal enzymes are be-
lieved to participate in the classical MVA pathway, but like
PtM3K, they are still only computationally annotated and need to
be investigated experimentally. Discovery of new enzymes is an
important goal, since this may yield biocatalysts with improved
properties. This can lead to better process efficiencies where pro-
duction yields with current enzymes are not yet sufficient for com-
mercial viability and where enzyme stability can be a problem.
Therefore, discovery of new enzymes of the MVA pathways could
aid in improved metabolic engineering for efficient, sustainable
bioproduction of chemicals and fuels.
ACKNOWLEDGMENTS
This work was supported by the University of Nottingham and by Lucite
International (United Kingdom).
We thank Benjamin Gleadhill and Shaz Aslam (School of Chemistry,
University of Nottingham) for performing ESI-MS and NMR analyses.
REFERENCES
1. Bloch K. 1965. The biological synthesis of cholesterol. Science 150:19 –28.
http://dx.doi.org/10.1126/science.150.3692.19.
2. Kuzuyama T, Seto H. 2012. Two distinct pathways for essential metabolic
precursors for isoprenoid biosynthesis. Proc Jpn Acad Ser B Phys Biol Sci
88:41–52. http://dx.doi.org/10.2183/pjab.88.41.
3. Holstein SA, Hohl RJ. 2004. Isoprenoids: remarkable diversity of form
and function. Lipids 39:293–309. http://dx.doi.org/10.1007/s11745-004
-1233-3.
4. Gershenzon J, Dudareva N. 2007. The function of terpene natural prod-
ucts in the natural world. Nat Chem Biol 3:408 – 414. http://dx.doi.org/10
.1038/nchembio.2007.5.
5. Kirby J, Keasling JD. 2009. Biosynthesis of plant isoprenoids: perspec-
tives for microbial engineering. Annu Rev Plant Biol 60:335–355. http:
//dx.doi.org/10.1146/annurev.arplant.043008.091955.
6. Wilding EI, Brown JR, Bryant AP, Chalker AF, Holmes DJ, Ingraham
KA, Iordanescu S, So CY, Rosenberg M, Gwynn MN. 2000. Identifica-
tion, evolution, and essentiality of the mevalonate pathway for isopente-
nyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol 182:
4319 – 4327. http://dx.doi.org/10.1128/JB.182.15.4319-4327.2000.
7. Misawa N. 2011. Pathway engineering for functional isoprenoids. Curr
Opin Biotechnol 22:627– 633. http://dx.doi.org/10.1016/j.copbio.2011.01
.002.
8. Dahl RH, Zhang F, Alonso-Gutierrez J, Baidoo E, Batth TS, Redding-
Johanson AM, Petzold CJ, Mukhopadhyay A, Lee TS, Adams PD,
Keasling JD. 2013. Engineering dynamic pathway regulation using stress-
response promoters. Nat Biotechnol 31:1039 –1046. http://dx.doi.org/10
.1038/nbt.2689.
9. Yuan J, Ching CB. 2014. Combinatorial engineering of mevalonate path-
way for improved amorpha-4,11-diene production in budding yeast. Bio-
technol Bioeng 111:608 – 617. http://dx.doi.org/10.1002/bit.25123.
10. Alonso-Gutierrez J, Chan R, Batth TS, Adams PD, Keasling JD, Petzold
CJ, Lee TS. 2013. Metabolic engineering of Escherichia coli for limonene
and perillyl alcohol production. Metab Eng 19:33– 41. http://dx.doi.org
/10.1016/j.ymben.2013.05.004.
11. Kim J-H, Kim S-W, Nguyen DQ-A, Li H, Kim S-B, Seo Y-G, Yang J-K,
Chung I-Y, Kim D-H, Kim C-J. 2009. Production of -carotene by
recombinant Escherichia coli with engineered whole mevalonate pathway
in batch and fed-batch cultures. Biotechnol Bioprocess Eng 14:559 –564.
http://dx.doi.org/10.1007/s12257-008-0230-1.
12. Jang H-J, Yoon S-H, Ryu H-K, Kim J-H, Wang C-L, Kim J-Y, Oh D-K,
Kim S-W. 2011. Retinoid production using metabolically engineered
Escherichia coli with a two-phase culture system. Microb Cell Fact 10:59.
http://dx.doi.org/10.1186/1475-2859-10-59.
13. Scalcinati G, Knuf C, Partow S, Chen Y, Maury J, Schalk M, Daviet L,
Nielsen J, Siewers V. 2012. Dynamic control of gene expression in Sac-
charomyces cerevisiae engineered for the production of plant sesquiterpene
-santalene in a fed-batch mode. Metab Eng 14:91–103. http://dx.doi.org
/10.1016/j.ymben.2012.01.007.
14. Zhu F, Zhong X, Hu M, Lu L, Deng Z, Liu T. 2014. In vitro reconsti-
tution of mevalonate pathway and targeted engineering of farnesene over-
production in Escherichia coli. Biotechnol Bioeng 111:1396 –1405. http:
//dx.doi.org/10.1002/bit.25198.
15. Wang C, Yoon S-H, Jang H-J, Chung Y-R, Kim J-Y, Choi E-S, Kim S-W.
2011. Metabolic engineering of Escherichia coli for -farnesene produc-
tion. Metab Eng 13:648 – 655. http://dx.doi.org/10.1016/j.ymben.2011.08
.001.
16. Gupta D, Summers ML, Basu C. 2014. Engineering an isoprenoid pathway
in Escherichia coli for production of 2-methyl-3-buten-2-ol: a potential
biofuel. Mol Biotechnol 56:516 –523. http://dx.doi.org/10.1007/s12033
-013-9721-1.
17. Zheng Y, Liu Q, Li L, Qin W, Yang J, Zhang H, Jiang X, Cheng T,
Liu W, Xu X, Xian M. 2013. Metabolic engineering of Escherichia coli
for high-specificity production of isoprenol and prenol as next generation
of biofuels. Biotechnol Biofuels 6:57. http://dx.doi.org/10.1186/1754
-6834-6-57.
18. Gogerty DS, Bobik TA. 2010. Formation of isobutene from 3-hydroxy-
3-methylbutyrate by diphosphomevalonate decarboxylase. Appl Environ
Microbiol 76:8004 – 8010. http://dx.doi.org/10.1128/AEM.01917-10.
19. Obenaus F, Droste W, Neumeister J. 15 June 2000. Butenes. In Ull-
mann’s encyclopedia of industrial chemistry. Wiley-VCH Verlag GmbH
& Co. KGaA, Weinheim, Germany. http://dx.doi.org/10.1002/14356007
.a04_483.
20. van Leeuwen BNM, Wulp AM, Duijnstee I, Maris AJA, Straathof AJJ.
2012. Fermentative production of isobutene. Appl Microbiol Biotechnol
93:1377–1387. http://dx.doi.org/10.1007/s00253-011-3853-7.
21. de Guzman D. 29 July 2011. Rubber industry seeks bio-based chemicals
potential. ICIS Chemical Business, London, England. http://www.icis.co
m/Articles/2011/07/01/9481223/Rubber-industry-seeks-bio-based-chem
icals-potential.html.
22. Organization for Economic Cooperation and Development. 2003.
Screening Information Data Set (SIDS) initial assessment report: isobuty-
M3K from P. torridus
April 2015 Volume 81 Number 7 aem.asm.org 2633Applied and Environmental Microbiology
 o
n
 M
arch 12, 2015 by Univ of Nottingham
http://aem
.asm
.org/
D
ow
nloaded from
 
lene. CAS no. 115-11-7. Organization for Economic Cooperation and
Development (OECD), Paris, France. http://www.inchem.org/documents
/sids/sids/115117.pdf.
23. Global Bioenergies. 2014. Global Bioenergies and Fraunhofer CBP take the
next step towards the set-up of the Leuna industrial pilot. Global Bioenergies,
Evry, France. http://www.global-bioenergies.com/communiques/140703_pr
_en.pdf.
24. Marliere P. March 2011. Method for the enzymatic production of 3-hy-
droxy-3-methylbutyric acid from acetone and acetyl-CoA. Patent
WO2011032934A1.
25. Marliere P. January 2010. Production of alkenes by enzymatic decarbox-
ylation of 3-hydroxyalkanoic acids. Patent WO2010001078A2.
26. Anissimova M, Delcourt M, Marliere P, Tallon R. April 2012. Produc-
tion of alkenes by combined enzymatic conversion of 3-hydroxyalkanoic
acids using different mevalonate pyrophosphate decarboxylases. Patent
WO2012052427A1.
27. Marliere P, Anissimova M, Chayot R, Delcourt M. June 2011. Process
for the production of isoprenol from mevalonate employing a diphospho-
mevalonate decarboxylase. Patent WO2011076261A1.
28. Delcourt M, Anissimova M, Marliere P. October 2013. Enzymatic pro-
duction of isoprenol from mevalonate by diphosphomevalonate decar-
boxylases. Patent WO2013150100A1.
29. Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ,
Ostell J, Sayers EW. 2013. GenBank. Nucleic Acids Res 41:D36 –D42.
http://dx.doi.org/10.1093/nar/gks1195.
30. UniProt Consortium. 2014. Activities at the Universal Protein Resource
(UniProt). Nucleic Acids Res 42:D191–D198. http://dx.doi.org/10.1093
/nar/gkt1140.
31. Vinokur JM, Korman TP, Cao Z, Bowie JU. 2014. Evidence of a novel
mevalonate pathway in archaea. Biochemistry 53:4161– 4168. http://dx
.doi.org/10.1021/bi500566q.
32. Azami Y, Hattori A, Nishimura H, Kawaide H, Yoshimura T, Hemmi
H. 2014. (R)-Mevalonate 3-phosphate is an intermediate of the meval-
onate pathway in Thermoplasma acidophilum. J Biol Chem 289:15957–
15967. http://dx.doi.org/10.1074/jbc.M114.562686.
33. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W,
Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res 25:3389 –3402. http:
//dx.doi.org/10.1093/nar/25.17.3389.
34. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accu-
racy and high throughput. Nucleic Acids Res 32:1792–1797. http://dx.doi
.org/10.1093/nar/gkh340.
35. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6:
Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 30:
2725–2729. http://dx.doi.org/10.1093/molbev/mst197.
36. Gouet P, Robert X, Courcelle E. 2003. ESPript/ENDscript: extracting
and rendering sequence and 3D information from atomic structures of
proteins. Nucleic Acids Res 31:3320 –3323. http://dx.doi.org/10.1093/nar
/gkg556.
37. Barta ML, McWhorter WJ, Miziorko HM, Geisbrecht BV. 2012. Structural
basis for nucleotide binding and reaction catalysis in mevalonate diphosphate
decarboxylase. Biochemistry 51:5611–5621. http://dx.doi.org/10.1021/bi300
591x.
38. Barta ML, Skaff DA, McWhorter WJ, Herdendorf TJ, Miziorko HM,
Geisbrecht BV. 2011. Crystal structures of Staphylococcus epidermidis me-
valonate diphosphate decarboxylase bound to inhibitory analogs reveal
new insight into substrate binding and catalysis. J Biol Chem 286:23900 –
23910. http://dx.doi.org/10.1074/jbc.M111.242016.
39. Krepkiy DV, Miziorko HM. 2005. Investigation of the functional contribu-
tions of invariant serine residues in yeast mevalonate diphosphate decarbox-
ylase. Biochemistry 44:2671–2677. http://dx.doi.org/10.1021/bi0484217.
40. Krepkiy DV, Miziorko HM. 2004. Identification of active site residues in
mevalonate diphosphate decarboxylase: implications for a family of phos-
photransferases. Protein Sci 13:1875–1881. http://dx.doi.org/10.1110/ps
.04725204.
41. Alvear M, Jabalquinto AM, Eyzaguirre J, Cardemil E. 1982. Purification and
characterization of avian liver mevalonate-5-pyrophosphate decarboxylase.
Biochemistry 21:4646–4650. http://dx.doi.org/10.1021/bi00262a020.
42. Dhe-Paganon S, Magrath J, Abeles RH. 1994. Mechanism of mevalonate
pyrophosphate decarboxylase: evidence for a carbocationic transition state.
Biochemistry 33:13355–13362. http://dx.doi.org/10.1021/bi00249a023.
43. Vinokur JM, Korman TP, Sawaya MR, Collazo M, Cascio D, Bowie JU.
2015. Structural analysis of mevalonate-3-kinase provides insight into the
mechanisms of isoprenoid pathway decarboxylases. Protein Sci 24:212–
220. http://dx.doi.org/10.1002/pro.2607.
44. Vannice JC, Skaff DA, Keightley A, Addo JK, Wyckoff GJ, Miziorko
HM. 2014. Identification in Haloferax volcanii of phosphomevalonate de-
carboxylase and isopentenyl phosphate kinase as catalysts of the terminal
enzyme reactions in an archaeal alternate mevalonate pathway. J Bacteriol
196:1055–1063. http://dx.doi.org/10.1128/JB.01230-13.
45. Dellas N, Thomas ST, Manning G, Noel JP. 2013. Discovery of a meta-
bolic alternative to the classical mevalonate pathway. eLife 2:e00672. http:
//dx.doi.org/10.7554/eLife.00672.
46. Pressman D, Lucas HJ. 1940. The hydration of unsaturated compounds.
VIII. The rate of hydration of ,-dimethylacrylic acid: the rates of dehy-
dration and decarboxylation of -hydroxyisovaleric acid. J Am Chem Soc
62:2069 –2080.
47. Byres E, Alphey MS, Smith TK, Hunter WN. 2007. Crystal structures of
Trypanosoma brucei and Staphylococcus aureus mevalonate diphosphate
decarboxylase inform on the determinants of specificity and reactivity. J
Mol Biol 371:540 –553. http://dx.doi.org/10.1016/j.jmb.2007.05.094.
48. Voynova N, Fu Z, Battaile K, Herdendorf T, Kim J, Miziorko H. 2008.
Human mevalonate diphosphate decarboxylase: characterization, investi-
gation of the mevalonate diphosphate binding site, and crystal structure.
Arch Biochem Biophys 480:58 – 67. http://dx.doi.org/10.1016/j.abb.2008
.08.024.
49. Lefurgy ST, Rodriguez SB, Park CS, Cahill S, Silverman RB, Leyh TS.
2010. Probing ligand-binding pockets of the mevalonate pathway en-
zymes from Streptococcus pneumoniae. J Biol Chem 285:20654 –20663.
http://dx.doi.org/10.1074/jbc.M109.098350.
50. Chen M, Poulter CD. 2010. Characterization of thermophilic archaeal
isopentenyl phosphate kinases. Biochemistry 49:207–217. http://dx.doi
.org/10.1021/bi9017957.
51. Yaws CL. 2003. Yaws’ handbook of thermodynamic and physical prop-
erties of chemical compounds. Knovel Corporation, New York, NY.
Rossoni et al.
2634 aem.asm.org April 2015 Volume 81 Number 7Applied and Environmental Microbiology
 o
n
 M
arch 12, 2015 by Univ of Nottingham
http://aem
.asm
.org/
D
ow
nloaded from
 
